Year |
Citation |
Score |
2023 |
Joshi M, Dey P, De A. Recent advancements in targeted protein knockdown technologies-emerging paradigms for targeted therapy. Exploration of Targeted Anti-Tumor Therapy. 4: 1227-1248. PMID 38213543 DOI: 10.37349/etat.2023.00194 |
0.687 |
|
2023 |
Dey P, Gadewal N, De A. Pathogenic HER3 dimerization domain mutations create a structural bias towards un-conventional EGFR-HER3 signalling axis in breast cancer. International Journal of Biological Macromolecules. 242: 124765. PMID 37156315 DOI: 10.1016/j.ijbiomac.2023.124765 |
0.607 |
|
2022 |
Dey P, Joshi M, Mujawar A, Malhotra R, De A. Direct knockdown of phospho-PTM targets mediated by TRIM21 can improve personalized treatment in breast cancer. Cellular Oncology (Dordrecht). PMID 35834098 DOI: 10.1007/s13402-022-00693-6 |
0.466 |
|
2021 |
Goel S, Dey P, Dahiya D, Bhatia A. A not so worthless attempt to develop primary culture from breast FNAC/CNB samples! Tissue & Cell. 71: 101517. PMID 33677200 DOI: 10.1016/j.tice.2021.101517 |
0.375 |
|
2020 |
Mal A, Dey P, Hayes RM, McCarthy JV, Ray A, De A. Identification of Potential Phosphorylation in the Cytoplasmic Domain of Epithelial Cell Adhesion Molecule. Acs Omega. 5: 30808-30816. PMID 33324790 DOI: 10.1021/acsomega.0c02113 |
0.67 |
|
2020 |
Yan S, Dey P, Ziegler Y, Jiao X, Kim SH, Katzenellenbogen JA, Katzenellenbogen BS. Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer. Breast Cancer Research and Treatment. PMID 33001337 DOI: 10.1007/s10549-020-05948-0 |
0.433 |
|
2020 |
Dey P, Wang A, Ziegler Y, Kim SH, El-Ashry D, Katzenellenbogen JA, Katzenellenbogen BS. Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast Cancer. Cancers. 12. PMID 32961773 DOI: 10.3390/Cancers12092677 |
0.46 |
|
2020 |
Dey P, Kundu A, Han SH, Kim KS, Park JH, Yoon S, Kim IS, Kim HS. Biological Evaluation of Oxindole Derivative as a Novel Anticancer Agent against Human Kidney Carcinoma Cells. Biomolecules. 10. PMID 32878322 DOI: 10.3390/biom10091260 |
0.318 |
|
2019 |
Dey P, Rathod M, De A. Targeting stem cells in the realm of drug-resistant breast cancer. Breast Cancer (Dove Medical Press). 11: 115-135. PMID 30881110 DOI: 10.2147/BCTT.S189224 |
0.733 |
|
Show low-probability matches. |